OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders
Catia Lambertucci, Gabriella Marucci, Daniela Catarzi, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 28, pp. 4780-4795
Closed Access | Times Cited: 15

Showing 15 citing articles:

Effects of the adenosine A2A receptor antagonist KW6002 on the dopaminergic system, motor performance, and neuroinflammation in a rat model of Parkinson's disease
Kavya Prasad, Erik F. J. de Vries, Esther van der Meiden, et al.
Neuropharmacology (2024) Vol. 247, pp. 109862-109862
Open Access | Times Cited: 6

Caffeine: A Multifunctional Efficacious Molecule with Diverse Health Implications and Emerging Delivery Systems
Xinjie Song, Mahendra Singh, Kyung Eun Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12003-12003
Open Access | Times Cited: 5

A2A Adenosine Receptor as a Potential Therapeutic Target in Cystitis-Induced Bladder Pain: Insights from a Transgenic Autoimmune Cystitis Murine Model
Hai‐Peng Ren, Xiang-yuan Wu, Jian Wang, et al.
International Urogynecology Journal (2025)
Closed Access

Exploring Trisubstituted adenine derivatives as adenosine A1 receptor ligands with antagonist activity: Synthesis, biological evaluation and molecular modelling
Laura B. Córdoba-Gómez, Álvaro Lorente‐Macías, Marı́a Isabel Loza, et al.
Bioorganic Chemistry (2025), pp. 108395-108395
Closed Access

“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
Andrea Spinaci, Michela Buccioni, Daniela Catarzi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 167-167
Open Access | Times Cited: 8

A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
Andrea Spinaci, Catia Lambertucci, Michela Buccioni, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2386-2386
Open Access | Times Cited: 9

GPCR-Mediated Natural Products and Compounds: Potential Therapeutic Targets for the Treatment of Neurological Diseases
Xing Xia Wang, Xiang Ji, Jing‐Jer Lin, et al.
Pharmacological Research (2024) Vol. 208, pp. 107395-107395
Open Access | Times Cited: 1

Design, Synthesis and Assay of Novel Methylxanthine–Alkynylmethylamine Derivatives as Acetylcholinesterase Inhibitors
D. V. Reshetnikov, Igor D. Ivanov, Dmitry S. Baev, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8787-8787
Open Access | Times Cited: 5

Adenosine A2A Receptor Antagonists: Chemistry, SARs, and Therapeutic Potential
Andrea Spinaci, Michela Buccioni, Chang Cui, et al.
Topics in medicinal chemistry (2023), pp. 101-141
Closed Access | Times Cited: 2

A Potential Use of Vidarabine: Alleviation of Functional Constipation Through Modulation of the Adenosine A2A Receptor-MLC Signaling Pathway and the Gut Microbiota
Xiaoyu Gao, Kaifeng Guo, Shuangfeng Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12810-12810
Open Access

The Neuroprotective Role of A2A Adenosine Purinoceptor Modulation as a Strategy Against Glioblastoma
Júlia Leão Batista Simões, Geórgia de Carvalho Braga, Michelli Fontana, et al.
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1286-1286
Open Access

A2AR antagonist treatment for multiple sclerosis: Current progress and future prospects
Chen-Xing Qi, Yijia Feng, Yiwei Jiang, et al.
International review of neurobiology (2023), pp. 185-223
Closed Access

Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders
Beatrice Francucci, Simone Angeloni, Diego Dal Ben, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4762-4762
Open Access

A2AR and traumatic brain injury
Yan Zhao, Ya‐Lei Ning, Yuan‐Guo Zhou
International review of neurobiology (2023), pp. 225-265
Closed Access

Promising Targets and Strategies to Control Neuroinflammation (Part II)
Stephanie Federico, Stefano Moro
Current Medicinal Chemistry (2022) Vol. 29, Iss. 28, pp. 4779-4779
Closed Access

Page 1

Scroll to top